ELISA Kit
CN β US| HS Code | Tariff Rate | Origin | Destination | Doc |
|---|---|---|---|---|
| 3006931000 | 10.0% | CN | US | Official Doc |
| 3006938000 | 40.0% | CN | US | Official Doc |
| 3002150091 | 10.0% | CN | US | Official Doc |
| 3002140090 | 10.0% | CN | US | Official Doc |
| 3822190080 | 10.0% | CN | US | Official Doc |
Product Images
AI Analysis
π§ͺ ELISA Kit (Enzyme-Linked Immunosorbent Assay Kit)
π HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
π I. Product Definition & Classification: What Exactly is an "ELISA Kit"?
An ELISA Kit is a critical diagnostic tool used in clinical research, clinical trials, and laboratory settings. It typically consists of microtiter plates, reagents, buffers, and controls designed to detect the presence of specific antigens or antibodies in a sample.
In international trade, ELISA kits are often categorized based on their clinical trial status, material composition, and specific function:
- Clinical Trial Kits (Placebo/Blind): Used as part of a blinded study, packaged with drug formulations.
- Immunoassay Reagents: Based on biological or immunological principles (e.g., detecting antibodies).
- General Diagnostic/Chemical Reagents: Laboratory kits that do not fit strictly into immunological categories or contain mixed chemical components.
β οΈ Key Distinction Point:
- If the kit is explicitly a placebo or blind control for clinical trials β Consider 3006.93
- If it is a biological/immunological test β Consider 3002.15 / 3002.14
- If it is a general diagnostic/chemical reagent β Consider 3822.19
π¦ II. HS Code Classification Details (2026 Latest Tariff Authority Mapping)
Based on the provided data, here are the 5 possible HS Codes for an ELISA Kit, along with their rationale and tax implications.
| HS Code | Product Description | Application Scenario | Rationale for Classification | Total Tax Rate |
|---|---|---|---|---|
3006.93.10.00 |
Clinical Trial Placebo/Blind Kit | Clinical trials, drug development | Acts as a placebo or blind test suite, packaged with drugs. No material conflict. Matches "medical supplies" logic. | 10.0% |
3006.93.80.00 |
Other Chemical Substances in Clinical Kits | General clinical trial kits | Contains chemical substances other than the drug itself. Based on common sense, ingredients are chemical preparations. | 40.0% |
3002.15.00.91 |
Other Immunoassays / Biological Preparations | Diagnostic tests for antibodies/antigens | ELISA is inherently an immunoassay. Common form of biological/immunological products. No material conflict. | 10.0% |
3002.14.00.90 |
Other Immunological Products | Specific immuno-logical diagnostics | ELISA kits are immunoassay tools. Since specific ingredients aren't defined, falls under "other" immunological items. No conflict. | 10.0% |
3822.19.00.80 |
Diagnostic/Laboratory Reagents | General lab diagnostics | Common format for diagnostic or lab reagents. Fits the category of "diagnostic or laboratory reagents." No material/use conflict. | 10.0% |
π Critical Insight:
- 3006.93.10.00 is the most favorable if the kit is specifically for clinical trials as a placebo/blind tool.
- 3006.93.80.00 carries the highest tax (40%) due to additional duties. Avoid this unless the chemical nature is strictly defined and cannot be classified under immunological (3002) or general diagnostic (3822).
- 3002.15/3002.14 are strong candidates for immunological diagnostics (common for ELISA).
- 3822.19.00.80 is a safe fallback for general lab reagents if immunological classification is disputed.
π° III. 2026 Latest Tariff Rate Breakdown (Including Additional Duties & Policy Surcharges)
β Applicable Country: United States (US)
β Origin: China (CN)
β Effective Date: From November 10, 2025 (and onwards)
π― 1. 3006.93.10.00 β Clinical Trial Placebo/Blind Kit (Lowest Risk & Cost)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value Γ 10% |
| De Minimis Eligibility | β No (Likely subject to Section 321 limitations for certain medical/chemical items, but specifically highlighted as non-exempt in context) |
| Legal Basis Path | IEEPA:9903.01.25 β USITC:3006.93.10.00 β FOOTNOTE:122 |
π Explanation:
- Base Duty: 0% for medical/supplies in this subcategory.
- IEEPA 10%: Applies to Chinese-origin goods under international emergency economic powers.
- No Section 301: This specific sub-item benefits from a waiver or lower classification under current trade rules.
- Strategic Advantage: Lowest tax burden among all options. Ideal if the kit can be justified as a "clinical trial placebo" or "medical supply."
π― 2. 3006.93.80.00 β Other Clinical Trial Kits (High Tax Warning)
| Item | Details |
|---|---|
| Base Duty Rate | 5.0% |
| Section 301 (USITC) Surcharge | +25.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 40.0% |
| Tax Calculation | CIF Value Γ 40% |
| De Minimis Eligibility | β No |
| Legal Basis Path | IEEPA:9903.01.25 β IEEPA:9903.01.24 β USITC:3006.93.80.00 β FOOTNOTE:9903.88.01 |
π Explanation:
- This code captures "other chemical substances" in clinical kits not otherwise specified.
- High Risk: Attracts all three taxes (Base + 301 + IEEPA).
- Avoidance Strategy: Only use if the product is explicitly a chemical reagent not fitting immunoassay (3002) or diagnostic reagent (3822) definitions.
π― 3. 3002.15.00.91 & 3002.14.00.90 β Immunological Products (Moderate Tax, High Accuracy)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value Γ 10% |
| De Minimis Eligibility | β No |
| Legal Basis Path | IEEPA:9903.01.25 β USITC:3002.15.00.91 / 3002.14.00.90 |
π Explanation:
- ELISA is fundamentally an immunological test.
- These codes have 0% base duty and 0% Section 301, only subject to the 10% IEEPA surcharge.
- Strong Candidate: Highly recommended if the kit detects antibodies/antigens.
- Distinction:
-3002.15: Broader "other immunoassays."
-3002.14: "Other immunological products."
- Choose based on specific regulatory definitions; both yield the same 10% total tax.
π― 4. 3822.19.00.80 β Diagnostic/Laboratory Reagents (Safe Fallback)
| Item | Details |
|---|---|
| Base Duty Rate | 0.0% |
| Section 301 (USITC) Surcharge | 0.0% |
| Section 122 (IEEPA) Surcharge | +10.0% |
| Total Effective Rate | 10.0% |
| Tax Calculation | CIF Value Γ 10% |
| De Minimis Eligibility | β No |
| Legal Basis Path | IEEPA:9903.01.25 β USITC:3822.19.00.80 |
π Explanation:
- If the kit is not purely immunological (e.g., contains non-specific chemical reagents), this code applies.
- Same 10% total tax as immunological codes.
- Versatility: Useful if the product description emphasizes "diagnostic" or "lab reagent" over "immunoassay."
π οΈ IV. Customs Clearance Practical Advice (Avoiding Pitfalls)
β 1. Documentation Checklist (Non-Negotiable)
| Document | Mandatory? | Description |
|---|---|---|
| β Product Specification Sheet | βοΈ | Must detail ingredients, intended use (clinical trial vs. diagnostic), and methodology. |
| β Clinical Trial Protocol (if applicable) | βοΈ | If claiming 3006.93.10.00, provide proof it's used as a placebo/blind kit in a trial. |
| β Ingredients List (COA) | βοΈ | Crucial for distinguishing between 3002 (immunological) and 3822 (chemical). |
| β Commercial Invoice | βοΈ | Clearly state "ELISA Kit" and intended use. Avoid vague terms like "Chemical Reagent" if it's immunological. |
| β Certificate of Origin | βοΈ | Required for IEEPA surcharge determination. |
| β FDA Registration/Listing (if US-bound) | βοΈ | ELISA kits often require FDA 510(k) or exemption status. |
β 2. Classification Strategy (Key Mantra)
π₯ βUse defines Code, Immunology is 10%, Placebo is 10%, Chemical is 40%!β
| Scenario | Recommended HS Code | Tax Rate | Risk Level |
|---|---|---|---|
| Kit used as Placebo/Blind in Clinical Trials | 3006.93.10.00 |
10% | π’ Low |
| ELISA for Antibody/Antigen Detection (Immunoassay) | 3002.15.00.91 / 3002.14.00.90 |
10% | π’ Low |
| General Lab Diagnostic Reagent (Non-immunological) | 3822.19.00.80 |
10% | π’ Low |
| Clinical Kit with Unspecified Chemical Components | 3006.93.80.00 |
40% | π΄ High |
β οΈ Critical Warning:
- Do NOT default to3006.93.80.00unless you are certain the product is a "chemical substance" not fitting immuno/diagnostic categories. The 30% tax difference is significant.
- ELISA is inherently immunological. Prefer3002codes unless you have strong evidence it's a non-immunological chemical test.
β 3. Special Circumstances Handling
| Situation | Handling Advice |
|---|---|
| OEM/Private Label Kits | Provide manufacturerβs certificate of analysis (COA) to prove immunological nature. |
| Mixed Contents (Reagents + Plates) | Declare as a complete kit. Do not split components; split declarations may trigger higher duties for each part. |
| Used for Research Only (Not Clinical) | Still eligible for 3002 or 3822 if intended for diagnostic-like detection. Clearly label "For Research Use Only" (RUO) if not FDA-cleared. |
| Origin: Non-China (e.g., Germany, USA) | IEEPA 10% surcharge does NOT apply. Tax rate drops to 0% (Base + 301 may still apply depending on product). |
π V. Global Market Comparison (2026)
| Market | Recommended HS Code | Total Tax (China Origin) | Key Certification |
|---|---|---|---|
| πΊπΈ United States | 3002.15.00.91 / 3006.93.10.00 |
10% (IEEPA only) | FDA 510(k) / Exemption |
| πͺπΊ European Union | 3822.19 / 3002.90 |
0%~6.5% (VAT applies) | CE Marking, IVD Directive |
| π¨π³ China | 3822.19 / 3002.90 |
0%~5% | NMPA Registration |
| π―π΅ Japan | 3822.19 / 3002.90 |
0%~6% | PMDA Approval |
π Conclusion:
- US Market: Highest complexity due to IEEPA 10% surcharge. Avoid3006.93.80.00at all costs.
- EU/JP/CN: Lower tariffs, but stricter regulatory approvals (CE, PMDA, NMPA) for ELISA kits.
π VI. Common Errors & Pitfalls (Lessons Learned)
β Error 1: Classifying ELISA Kit as 3006.93.80.00
π Consequence: 40% tax instead of 10%. Huge cost increase.
β
Fix: Prove immunological nature (3002) or clinical placebo use (3006.93.10).
β Error 2: Declaring as "Chemical Reagent" when it's Immunological
π Consequence: Misclassification risk, potential penalty, and loss of preferential rates.
β
Fix: Use precise terms like "Immunoassay Kit" or "Antibody Detection Kit."
β Error 3: Ignoring IEEPA Surcharge
π Consequence: Underestimating landed cost by 10%.
β
Fix: Always add 10% to base duty for Chinese-origin goods in these categories.
π― VII. Conclusion: Precision Classification, Cost Efficiency
π― Remember the Mantra:
πΉ "ELISA is Immuno: Use 3002, Pay 10%.
Placebo is Clinical: Use 3006.10, Pay 10%.
Avoid 3006.80, or Pay 40%!"
πΉ "HS Code Determines Profit; 30% Difference Can Break Your Margin!"
π Pro Tip:
If your ELISA Kit is originating from the EU, USA, or Japan, the IEEPA 10% surcharge is waived. Total tax may be 0% (depending on base rate and 301 applicability). Always verify origin!
π£ Immediate Action:
π Consult with a licensed customs broker.
π Submit a Product Composition Analysis to justify3002or3822classification.
π Optimize your supply chain to leverage non-China origins if tax savings are critical.
β¨ Professional Clearance Starts with Accurate Classification!
πΌ Every Percentage Point of Tax Savings is Pure Profit!
Customer Reviews
About HS Code Classification
The Harmonized System (HS) is an internationally standardized nomenclature developed by the World Customs Organization (WCO) to classify traded products. Over 200 countries use the HS system as the basis for customs tariffs, trade statistics, and import/export regulations.
Each HS code follows a hierarchical structure:
- Chapter (2 digits) β Broad category of goods (e.g., Chapter 84: Machinery and Mechanical Appliances)
- Heading (4 digits) β More specific grouping within the chapter
- Subheading (6 digits) β Internationally standardized breakdown, used by all WCO member countries
- National subdivisions (8-10 digits) β Country-specific extensions for further classification, such as US HTSUS 10-digit codes
Correct HS code classification is essential for smooth customs clearance, accurate duty payment, and compliance with trade regulations. Misclassification can lead to customs delays, overpayment of duties, or penalties.
When importing from CN to US, the applicable tariff rates may include:
- Most-Favored-Nation (MFN) rate β The standard duty rate applied to WTO members
- General rate β Applied to countries without trade agreements
- Trade remedy duties β Additional tariffs such as Section 301 (anti-dumping), Section 232 (national security), or countervailing duties
The information provided on this page is for reference purposes only. For official classification, please consult with your local customs authority or a licensed customs broker.